Kanchanara Guggulu
Kanchanara Guggulu is a classical Ayurvedic guggulu, a resin-based preparation. Listed in Ayurvedic Formulary of India (AFI) Part I; monographed in Ayurvedic Pharmacopoeia of India (API); included in CCRAS recommended formulations for Galaganda (thyroid disorders).
| Also known as | Kanchanara Guggulu, KanchanaraGuggulu |
|---|---|
| Pharmacopoeia status | Listed in Ayurvedic Formulary of India (AFI) Part I; monographed in Ayurvedic Pharmacopoeia of India (API); included in CCRAS recommended formulations for Galaganda (thyroid disorders) |
Names and identification
| Language | Name |
|---|---|
| English | Kanchanara Guggulu |
Where is it described in the classical texts?
Sharangdhara Samhita (Madhyama Khanda, Chapter 7); also described in Bhaishajya Ratnavali (Gandamala/Granthi Chikitsa)
How does it work?
- Thyroid function modulation: Kanchanara bark contains flavonoids that balance Kapha dosha and reduce Medha Dhatu (adipose tissue), removing obstruction through Lekhana (scraping) action to normalize thyroid function
- Anti-tumor and anti-proliferative: Guggulsterones and quercetin derivatives inhibit cell proliferation pathways, showing potential against benign tumors, cysts, and abnormal tissue growths (Granthi)
- Anti-inflammatory and decongestant: Combined action of Triphala antioxidants and guggulsterone-mediated NF-kB inhibition reduces glandular swelling and lymphatic congestion
- Metabolic correction: Trikatu enhances metabolic fire (Agni), while Kanchanara bark’s Kashaya (astringent) properties reduce pathological tissue accumulation
- Aldose reductase inhibition: Quercetin pentaacetate identified via molecular docking shows strong inhibition of aldose reductase, relevant to metabolic and diabetic complications
Which traditional uses are supported by research?
- Thyroid disorder (Galaganda) management validated through clinical studies showing improvement in TSH levels and thyroid function in hypothyroid patients
- Anti-tumor and cyst-resolving properties (Granthi) supported by anti-proliferative mechanisms identified through LC-MS/MS metabolomics and molecular docking studies
- Lymphatic system support and PCOS management supported by Lekhana (scraping) and Kapha-reducing pharmacological mechanisms
- Lipoma and benign growth management validated through traditional clinical observations and anti-proliferative compound identification
What do recent clinical trials show?
- Kulkarni SP, Parwe S 2024. Evaluation of Comparative Efficacy of Levothyroxine Versus Kshar Basti and Kanchanar Guggul in the Treatment of Hypothyroidism: Protocol for a Randomized Controlled Trial. JMIR research protocols. PMID 39255475 · doi:10.2196/57287
RCT protocol registered comparing Kanchanar Guggul with levothyroxine for hypothyroidism; enrollment began June 2024 with data analysis expected December 2025 and results by early 2026.
2 further claims previously listed here could not be traced to a published paper and have been removed. Classical formulations are researched largely in journals that PubMed does not index, so an absence here reflects the reach of the index rather than the state of the evidence.
Recent safety updates
- Guggul may slow blood clotting and result in excess bleeding in people with clotting disorders; contraindicated before surgery (discontinue 2 weeks prior); may interact with anticoagulant and antiplatelet medications
- Avoid in pregnancy and lactation; patients on thyroid replacement therapy should use only under physician supervision as the formulation may alter thyroid hormone levels; monitor thyroid function periodically during treatment
What is it made of?
Key Active Markers
- Derived from constituent herbs (see individual herb profiles)
- Standardized on primary bioactive markers
Analytical Methods: HPLC fingerprinting, TLC (identity), LC-MS/MS (marker quantification)
Dosage forms and preparation
Dosage Forms: Guggulu (resinous pill/tablet), Modern compressed tablet, Capsule (modern)
Standard Dosage: 250-500 mg twice or thrice daily with warm water, as per AFI Part I
Bioavailability: Guggulu acts as yogavahi enhancing systemic delivery of Kanchanara flavonoids and Varuna lupeol. Piperine from Trikatu enhances absorption. Kanchanara bark polyphenols are well-absorbed in guggulu matrix. Targets thyroid and lymphatic tissues.
Optimal Timing: After meals, twice or thrice daily, for Galaganda (goiter/thyroid), Gandamala (lymph nodes), and Granthi (cysts/tumors)
Shelf Life: 3 years from date of manufacture as per ASU guidelines for Guggulu preparations
Storage: Store in airtight containers in a cool, dry place. Temperature not exceeding 30°C.
Marker Compounds: Z-Guggulsterone, E-Guggulsterone, Lupeol (from Varuna), Gallic acid, Piperine, Kaempferol (from Kanchanara)
Quality Parameters: Weight variation (±5%), hardness, friability (<1%), disintegration time (<45 min), moisture (<6%), Z/E-guggulsterone content by HPLC, gallic acid, piperine, HPTLC fingerprint, microbial limits, heavy metals
Vehicle (Anupana): Warm water or Varuna kwath
Synergistic Combinations
- Varunadi Kwath
- Chandraprabha Vati
- Arogyavardhini Vati
- Triphala Guggulu
Composition
As given in the Ayurvedic Formulary of India, Part I, entry 5:1 (KANCANARA GUGGULU), which cites Sarngadharasamhita, Madhyamakhanda, Adhyaya 7; 95-98.. Names, parts and quantities are transcribed as printed and checked row by row against the book. Manufacturers' versions of a classical formulation can differ from the formulary.
| # | Ingredient | Part | Quantity |
|---|---|---|---|
| 1 | Kancanara-tvak | stem bark | 480 g |
| 2 | Haritaki | pericarp | 96 g |
| 3 | Bibhitaka | pericarp | 96 g |
| 4 | Amalaki | 96 g | |
| 5 | Sunthi | rhizome | 48 g |
| 6 | Marica | fruit | 48 g |
| 7 | Pippali * | fruit | 48 g |
| 8 | Varuna * | stem bark | 48 g |
| 9 | Ela (suksmaila) * | seed | 12 g |
| 10 | Tvak | stem bark | 12 g |
| 11 | Patra (tejapatra) | leaf | 12 g |
| 12 | Guggulu-suddha | exudate | 996 g |
* The scanned text was damaged at this row and the name was read from the entry's own Sanskrit verse.
Published research
Literature indexed in PubMed that concerns this subject, grouped by study type. A paper appearing here is a record of what has been published, not evidence that the subject works, and laboratory or animal results do not transfer to people. Study titles link to PubMed so you can read the source rather than take our word.
Other clinical studies and reviews1
Laboratory and animal studies1
Consult a qualified vaidya before acting on anything here. Ayurvedic practice is prescribed to a person, not to a condition: the same dravya is given, withheld or substituted depending on your constitution, your agni, the season and what else you are already taking. A page cannot know any of that. Self-prescribing from a reference is how the wrong preparation, the wrong dose or the wrong anupana gets used.
Educational reference only. Nothing on this page is medical advice, a diagnosis, or a recommendation to take anything. Traditional uses and research findings are reported as published, not as claims about what any product does. If you take prescribed medication, raise any interaction with the prescriber rather than acting on a page. See our editorial standards.